0001127602-23-030566.txt : 20231229
0001127602-23-030566.hdr.sgml : 20231229
20231229162419
ACCESSION NUMBER: 0001127602-23-030566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dahiyat Bassil I
CENTRAL INDEX KEY: 0001591312
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36182
FILM NUMBER: 231527993
MAIL ADDRESS:
STREET 1: C/O XENCOR, INC.
STREET 2: 111 WEST LEMON AVENUE
CITY: MONROVIA
STATE: CA
ZIP: 91016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xencor Inc
CENTRAL INDEX KEY: 0001326732
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 201622502
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
BUSINESS PHONE: 626-305-5900
MAIL ADDRESS:
STREET 1: 465 N. HALSTEAD ST.
STREET 2: SUITE 200
CITY: PASADENA
STATE: CA
ZIP: 91107
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-12-29
0001326732
Xencor Inc
XNCR
0001591312
Dahiyat Bassil I
C/O XENCOR, INC.
465 N HALSTEAD STREET, SUITE 200
PASADENA
CA
91107
1
1
PRESIDENT & CEO
0
Common Stock
2023-12-29
4
M
0
65001
11.05
A
357929
D
Common Stock
2023-12-29
4
S
0
45000
20.926
D
312929
D
Stock Option (Right to Buy)
11.05
2023-12-29
4
M
0
65001
0
D
2024-02-20
Common Stock
65001
0
D
Underlying option due to expire in February 2024.
Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 304 shares acquired in June 2023 and 408 shares acquired in December 2023.
Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.
/s/ Celia E. Eckert, Attorney-in-Fact
2023-12-29